- BNF:
- NL
- Status:
- Red
- Decision Date:
- November 2016
Comments
RED: 1,2,3 NICE TA413: for treating chronic hepatitis C. (Decision date - November 2016)
Red Drug Classifications
- 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
- 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
- 3: Requiring long term on-going monitoring of toxicity by a specialist (either because of difficulty in recognising side effects or high cost of investigations to identify toxicity)
search again